Nitrogen heterocycle biaryls for osteoporosis and other diseases

LETOURNEAU JEFFREY J, PARADKAR VIDYAHAR, OHLMEYER MICHAEL H, DILLARD LAWRENCE W, BALDWIN JOHN J, RIVIELLO CHRISTOPHER M, WONG ANGELA, RONG YAING, LETOURNEAU JEFFREY JOHN, OHLMEYER MICHAEL H. J, RIVIELLO CHRISTOPHER MARK
2008
OA: closed Metadata only
⚙ AI-generated summary by qwen3.7-flash, 2026-09-08 ⓘ

Nitrogen heterocycle biaryls with a carboxylate terminus are disclosed as useful for treating endometriosis, osteoporosis, restenosis, rheumatoid arthritis, cancer, macular degeneration, and obesity.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Nitrogen heterocycle biaryls having a carboxylate terminus are useful for treating endometriosis, osteoporosis, restenosis following angioplasty, rheumatoid arthritis, cancer, macular degeneration and obesity. Compounds of formula: are disclosed. A representative example is

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-29T06:27:48.050232+00:00